Biomerica, Inc. 

(Public, OTC:BMRA)   Watch this stock   
Find more results for BMRA
Oct 16, 2009
Q1 2010 Biomerica Earnings Release
Aug 31, 2009
Q4 2009 Biomerica Earnings Release
  

Key stats and ratios

Q3 (Aug '09) 2009
Net profit margin 0.70% 7.17%
Operating margin 0.52% 5.03%
EBITD margin - 6.83%
Return on average assets 0.62% 6.90%
Return on average equity 0.74% 8.60%
Employees 31 -

Address

1533 Monrovia Avenue
Newport Beach, CA 92663
United States - Map
+1-949-6452111 (Phone)
+1-949-7226674 (Fax)

Website links

Biomerica, Inc. discussions

  View all discussions »

Description

Biomerica, Inc. (Biomerica) is engaged in developing, manufacturing and marketing medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The Company's medical diagnostic products are sold worldwide in two markets: clinical laboratories and point of care (physicians' offices and over-the-counter drugstores). The diagnostic test kits are used to analyze blood or urine from patients in the diagnosis of various diseases and other medical complications, or to measure the level of specific hormones, antibodies, antigens or other substances, which may exist in the human body in small concentrations.

Officers and directors

Zackary Irani
Chairman of the Board, Chief Executive Officer
Age: 43
Janet Moore
Chief Financial Officer, Treasurer, Secretary, Director
Age: 58
Francis Capitanio
President - Diagnostics
Age: 65
Francis R. Cano Ph.D.
Director
Age: 62
Allen Barbieri
Director
Age: 51
Jane F. Emerson M.D., Ph.D.
Director
Age: 55